You are here

Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.

TitlePolygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.
Publication TypeJournal Article
Year of Publication2021
AuthorsSariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA, Paré G, Mayeux R, Tosto G
JournalAnn Neurol
Volume90
Issue3
Pagination366-376
Date Published2021 09
ISSN1531-8249
KeywordsAged, Aged, 80 and over, Alzheimer Disease, Caribbean Region, Cohort Studies, Databases, Genetic, Female, Follow-Up Studies, Genetic Predisposition to Disease, Hispanic or Latino, Humans, Male, Middle Aged, Multifactorial Inheritance, Risk Factors
Abstract

OBJECTIVE: Polygenic risk scores (PRSs) assess the individual genetic propensity to a condition by combining sparse information scattered across genetic loci, often displaying small effect sizes. Most PRSs are constructed in European-ancestry populations, limiting their use in other ethnicities. Here we constructed and validated a PRS for late-onset Alzheimer's Disease (LOAD) in Caribbean Hispanics (CH).
METHODS: We used a CH discovery (n = 4,312) and independent validation sample (n = 1,850) to construct an ancestry-specific PRS ("CH-PRS") and evaluated its performance alone and with other predictors using the area under curve (AUC) and logistic regression (strength of association with LOAD and statistical significance). We tested if CH-PRS predicted conversion to LOAD in a subsample with longitudinal data (n = 1,239). We also tested the CH-PRS in an independent replication CH cohort (n = 200) and brain autopsy cohort (n = 33). Finally, we tested the effect of ancestry on PRS by using European and African American discovery cohorts to construct alternative PRSs ("EUR-PRS", "AA-PRS").
RESULTS: The full model (LOAD ~ CH-PRS + sex + age + APOE-ɛ4), achieved an AUC = 74% (OR  = 1.51 95%CI = 1.36-1.68), raising to >75% in APOE-ɛ4 non-carriers. CH-PRS alone achieved an AUC = 72% in the autopsy cohort, raising to AUC = 83% in full model. Higher CH-PRS was significantly associated with clinical LOAD in the replication CH cohort (OR = 1.61, 95%CI = 1.19-2.17) and significantly predicted conversion to LOAD (HR = 1.93, CI = 1.70-2.20) in the longitudinal subsample. EUR-PRS and AA-PRS reached lower prediction accuracy (AUC = 58% and 53%, respectively).
INTERPRETATION: Enriching diversity in genetic studies is critical to provide an effective PRS in profiling LOAD risk across populations. ANN NEUROL 2021;90:366-376.

DOI10.1002/ana.26131
Pubmed Linkhttps://www.ncbi.nlm.nih.gov/pubmed/34038570?dopt=Abstract
page_expoInternal
Alternate JournalAnn Neurol
PubMed ID34038570
PubMed Central IDPMC8435026
Grant ListRC2 AG036528 / AG / NIA NIH HHS / United States
R56 AG066889 / AG / NIA NIH HHS / United States
R37 AG015473 / AG / NIA NIH HHS / United States
R56 AG069118 / AG / NIA NIH HHS / United States
R56AG051876 / NH / NIH HHS / United States
R01 AG037212 / AG / NIA NIH HHS / United States
U01AG016976 / NH / NIH HHS / United States
UL1 TR001873 / TR / NCATS NIH HHS / United States
R56AG069118 / NH / NIH HHS / United States
R01 AG067501 / AG / NIA NIH HHS / United States
R56 AG059756 / AG / NIA NIH HHS / United States
R01AG037212 / NH / NIH HHS / United States
RF1AG015473 / NH / NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
RF1 AG066107 / AG / NIA NIH HHS / United States
R56AG066889 / NH / NIH HHS / United States
R56AG063908 / NH / NIH HHS / United States
U01 AG016976 / AG / NIA NIH HHS / United States
RF1 AG054023 / AG / NIA NIH HHS / United States
RC2AG036528 / NH / NIH HHS / United States
U24 AG041689 / AG / NIA NIH HHS / United States
R56 AG063908 / AG / NIA NIH HHS / United States
RF1 AG015473 / AG / NIA NIH HHS / United States
R01AG067501 / NH / NIH HHS / United States
5R37AG015473 / NH / NIH HHS / United States
U24AG21886 / NH / NIH HHS / United States
U24AG041689 / NH / NIH HHS / United States

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer